China is a multicultural country that has arisen from its 56 ethnicities, with a diverse population of over 1.3 billion people and an imbalanced economic development. The health care system in China is tending to be overall funded through urban and rural health insurance plans. Although China has invested in the basic research of genome science, public health genomics-related programs and services in China started late. Prenatal screening is offered as part of routine clinical prenatal services and is free of charge in some economically advanced cities. Newborn screening programs are mandated throughout the country but vary between provinces and territories in terms of organization and diseases screened for; most screening tests are paid by out-of-pocket expenses. Genetic tests are encouraged while there are only one accredited state laboratory and few territorial laboratories in China. Further national genomics policies are needed in China in a range of genetic issues and infrastructure of public health genomics. Careful measurement is essential to understanding the nature and scale of the task ahead.

1.
Zhao J: China Geography. Beijing, Higher Education Press, 1999.
2.
Year Book, China, 2008. Beijing, National Bureau of Statistics, 2008, pp 79–80.
3.
Year Book, China, 1991. Beijing, National Bureau of Statistics, 1991, pp 79–81.
4.
Year Book, China, 2008. Beijing, National Bureau of Statistics, 2008, pp 315.
5.
World population prospects: the 2004 revision population database. New York, United Nations Population Division, 2006.
6.
Hu XJ, Cook S, Salazar MA: International migration and health in China. Lancet 2008;372:1717–1719.
7.
Wang F, Zuo XJ: Inside China’s cities: institutional barriers and opportunities for urban migrants. Am Econ Rev 1999;2:276–280.
8.
Roberts KD: China’s tidal wave of migrant labor: what can we learn from Mexican undocumented migration to the United States? Int Migr Rev 1997;31:249–293.
9.
Wang F, Zuo XJ, Ruan DC: Rural migrants in Shanghai: living under the shadow of socialism. Int Migr Rev 2002;36:520–545.
10.
Shen JF, Huang YF: The working and living space of the ‘floating population’ in China. Asia Pac Viewp 2003;44:51–62.
11.
Yang YM, Li Y, Liu CR: The situations and measures of infant birth qualities from 2000 to 2004. Chin Prim Health Care 2005;6:10–11.
12.
Zhan SK, Sun ZW, Erik B: Economic transition and maternal health care for internal migrants in Shanghai, China. Health Policy Plan 2002;17:47–55.
13.
Flaberty JH, Liu ML, Dong B, Ding QF, Li X, Xiao SF: China: the aging giant. J Am Geriatr Soc 2007;55:1295–1300.
14.
King M: China’s infamous one-child policy. Lancet 2005;365:215–216.
15.
Short SE, Zhai FY, Xu SY, Yang ML: China’s one-child policy and the care of children: an analysis of qualitative and quantitative data. Soc Forces 2001;79:913–943.
16.
Mao X, Wertz DC: China’s genetic services providers’ attitudes towards several ethical issues: a cross-cultural survey. Clin Genet 1997;2:100–109.
17.
Health Statistical Year Book, 2007. Beijing, Ministry of Health, 2007. Available at www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/200807/37168.htm.
18.
Ministry of Health. Urban medical service study in China – survey data on medical care demand and utilization from nine provinces and municipalities. Beijing, Ministry of Health, 1989.
19.
Liu Y, Rao K, Fei J: Economic transition and health transition: comparing China and Russia. Health Policy 1998;44:103–122.
20.
Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M: Tackling the challenges to health equity in China. Lancet 2008;372:1493–1501.
21.
Qiong E, Tang ZL, Huang JY, Han P, Tian D, Li CL, Chen YY: An analysis on will survey of prenatal screening for Down syndrome. Chin Prim Health Care 2008;8:33–35.
22.
www.sklmg.edu.cn/cn/index.aspx.
23.
Ren AG, Wang L, Zhao P, Li Z: Current status of genetic counseling in maternal and child health institutions. Chin J Reprod Health 2002;13:131–134.
24.
Zhang YZ, Zhong N: Current genetic counseling in China. J Peking Univ (Health Sciences) 2006;1:33–34.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.